Article info
PDFOriginal article
Prognostic significance of Claudin 12 in estrogen receptor-negative breast cancer
- Correspondence to Dr Omid Iravani, Department of Anatomy, Centre for Translational Medicine (CeTM), Yong Loo Lin School of Medicine, National University of Singapore, MD6, 14 Medical Drive, Singapore 117599, Singapore; antoi{at}nus.edu.sg
Citation
Prognostic significance of Claudin 12 in estrogen receptor-negative breast cancer
Publication history
- Received July 13, 2015
- Revised January 30, 2016
- Accepted February 3, 2016
- First published February 29, 2016.
Online issue publication
July 08, 2019
Article Versions
- Previous version (8 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/